Cancer treatment therapies: traditional to modern approaches to combat cancers

R Kaur, A Bhardwaj, S Gupta - Molecular biology reports, 2023 - Springer
As far as health issues are concerned, cancer causes one out of every six deaths around the
globe. As potent therapeutics are still awaited for the successful treatment of cancer, some …

[HTML][HTML] A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer

S Wu, J Lu, H Zhu, F Wu, Y Mo, L Xie, C Song, L Liu… - Cancer Letters, 2024 - Elsevier
Among patients with triple-negative breast cancer (TNBC), distant metastasis is the leading
cause of death. Our previous studies have shown that TNBC progression is greatly …

Recent advancement in the detection of potential cancer biomarkers using the nanomaterial integrated electrochemical sensing technique: a detailed review

H Bhardwaj, A Noumani, JK Himanshu… - Materials …, 2024 - pubs.rsc.org
Cancer is a leading cause of morbidity and mortality worldwide but early diagnosis,
management or screening and treatment of cancer can significantly improve the survival rate …

[HTML][HTML] circROBO1 promotes prostate cancer growth and enzalutamide resistance via accelerating glycolysis

Z Zhou, J Qin, C Song, T Wu, Q Quan, Y Zhang… - Journal of …, 2023 - ncbi.nlm.nih.gov
Background and aim: As non-coding RNAs, circular RNAs (circRNAs) contribute to the
progression of malignancies by regulating various biological processes. In prostate cancer …

PIWI-interacting RNA-YBX1 inhibits proliferation and metastasis by the MAPK signaling pathway via YBX1 in triple-negative breast cancer

L Wu, S Huang, W Tian, P Liu, Y Xie, Y Qiu, X Li… - Cell Death …, 2024 - nature.com
Breast cancer is the second leading cause of death in women worldwide, with triple-
negative breast cancer (TNBC) having the worst prognosis. Although there are numerous …

AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer

W Tian, Y Tang, Y Luo, J Xie, S Zheng, Y Zou… - Cell Death & …, 2023 - nature.com
Aurora-A kinase interacting protein 1 (AURKAIP1) has been proved to take an intermediary
role in cancer by functioning as a negative regulator of Aurora-A kinase. However, it remains …

[HTML][HTML] based screen-printed electrode to detect miRNA-652 associated to triple-negative breast cancer

A Raucci, W Cimmino, SP Grosso, N Normanno… - Electrochimica …, 2024 - Elsevier
Triple-negative breast cancer (TNBC) is one of the most aggressive and lethal types of BC,
affecting mostly young women and its diagnosis is difficult and requires invasive methods …

The role of gut microbiota and drug interactions in the development of colorectal cancer

J Wu, C Xia, C Liu, Q Zhang, C Xia - Frontiers in Pharmacology, 2023 - frontiersin.org
The human gut microbiota is a complex ecosystem regulating the host's environmental
interaction. The same functional food or drug may have varying bioavailability and distinct …

Intracellular self-aggregation of biomimetic Fe 3 O 4 nanoparticles for enhanced ferroptosis-inducing therapy of breast cancer

Z Zhang, B Xie, X Lu, L Xiong, X Li, Y Zhang, C Li… - Nanoscale, 2024 - pubs.rsc.org
Nanomedicines based on ferroptosis may be effective strategies for cancer therapy due to
their unique inducing mechanism. However, the challenges, including non-target …

Novel 2-substituted-quinoxaline analogs with potential antiproliferative activity against breast cancer: insights into cell cycle arrest, topoisomerase II, and EGFR activity

MG Salem, SAA El-Ata, EH Elsayed, SN Mali… - RSC …, 2023 - pubs.rsc.org
Breast cancer is a global health concern, with increasing disease burden and disparities in
access to healthcare. Late diagnosis and limited treatment options in underserved areas …